Incyte (INCY) Other Non-Current Liabilities (2013 - 2026)
Incyte (INCY) reported Other Non-Current Liabilities of $124.52 million for Q2 2026, down 30.8% from $179.91 million a year earlier and down 1.6% from the prior quarter.
Incyte (INCY) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Incyte posted Other Non-Current Liabilities of $165.27 million, down 1.4% from FY2024.
- Other Non-Current Liabilities has declined for nine consecutive years, with a five-year compound annual growth rate of -6.2% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $167.54 million in FY2024 (-3.5%), $173.58 million in FY2023 (-5.9%), $184.46 million in FY2022 (-10.9%) and $206.99 million in FY2021 (-9.1%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q1 2016.
- Year over year, Other Non-Current Liabilities has now declined in each of the last three quarters, with an average decline of 5.2% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q2 2025 (growth of 14.7%); the low point was Q2 2026 (a decline of 30.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $126.59 million (Q1 2026), $165.27 million (Q4 2025) and $171.18 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.52 Mn |
| Mar 31, 2026 | 126.59 Mn |
| Dec 31, 2025 | 165.27 Mn |
| Sep 30, 2025 | 171.18 Mn |
| Jun 30, 2025 | 179.91 Mn |
| Mar 31, 2025 | 175.59 Mn |
| Dec 31, 2024 | 167.54 Mn |
| Sep 30, 2024 | 166.67 Mn |
| Jun 30, 2024 | 156.85 Mn |
| Mar 31, 2024 | 164.84 Mn |
| Dec 31, 2023 | 173.58 Mn |
| Sep 30, 2023 | 170.19 Mn |
| Jun 30, 2023 | 179.49 Mn |
| Mar 31, 2023 | 180.83 Mn |
| Dec 31, 2022 | 184.46 Mn |
| Sep 30, 2022 | 171.81 Mn |
| Jun 30, 2022 | 200.09 Mn |
| Mar 31, 2022 | 204.13 Mn |
| Dec 31, 2021 | 206.99 Mn |
| Sep 30, 2021 | 213.78 Mn |
Incyte Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();